The Genome Engineering field has been revolutionized by CRISPR technologies, resulting in rapid, affordable and multiplex editing of genomes. Moreover, the number of CRISPR applications is continuously increasing. Next to this, progress in the Synthetic Biology field has been accelerated by recent developments in DNA synthesis and assembly technologies, and the expansion of the genetic code.
During this two day conference, the latest developments in the fields of Genome Engineering and Synthetic Biology will be presented by over 30 speakers from academia and industry. The world-renowned academics will showcase their latest research breakthroughs, while the technology developers in industry present their disruptive new technology platforms which drive the field forward.
Session topics are:
- DNA synthesis
- Synthetic organelles & cell-free synbio
- Mammalian & plant synthetic biology
- Computational biology
- CRISPR therapeutics
- Scaling-up CRISPR
After three successful editions (organized in Sept 2013, January 2016 and January 2018) featuring each time ~300 attendees, we hope to further increase the impact of our meeting in this field.
- Sarah Christine Heilshorn, Stanford University, US
- George Guo-Qiang Chen, Tsinghua University, CN
- Edward Lemke, Institute of Molecular Biology (IMB), DE, Johannes Gutenberg University (JGU), DE & EMBL, DE
- Christine Santos, Manus Bio, US
- Janice Chen, Mammoth Biosciences, US
- Patrick Yizhi Cai, Manchester Institute of Biotechnology, University of Manchester, UK
and many more